12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
After Tuesday's after-market session, several healthcare stocks experienced significant movements. Coherus BioSciences (CHRS) led the gainers with a 26.6% rise, while Oncternal Therapeutics (ONCT) saw the largest decline among the losers, dropping 13.7%. The article provides a snapshot of the after-market performance of these healthcare stocks, with market cap information included for context.
December 26, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coherus BioSciences stock rose significantly by 26.6% in after-market trading, indicating strong investor interest or a positive reaction to company-specific news.
The substantial after-market gain for Coherus BioSciences suggests a positive development or investor optimism, which could lead to a short-term upward trend in the stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Oncternal Therapeutics stock declined by 13.7% during after-market hours, reflecting negative investor sentiment or adverse news affecting the company.
The significant drop in Oncternal Therapeutics' stock price could be due to negative news or investor reactions, potentially leading to a short-term downtrend.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90